Concentrations


(a)	Products

There were no significant sales by product during 2012 at the Resources segment. In prior periods, significant sales by product, as percentage of consolidated revenues, were as follows at the Resources segment:



	2011		2010
Lanthanum products	23	%	39	%
Cerium products	11	%	29	%
Neodymium and Praseodymium products	26	%	26	%

The Chemicals and Oxides segment includes sales of REO, zirconium-based engineered materials and mixed rare earth/zirconium oxides from the Molycorp Canada acquisition on June 11, 2012, and REO from the Molycorp Silmet acquisition on April 1, 2011. Sales of cerium products within the Chemicals and Oxides segment accounted for approximately 15% of consolidated sales in 2012.

Within the Magnetic Materials and Alloys segment, sales of Neo Powders™ were approximately 25% of consolidated revenues for the period from June 12, 2012 to December 31, 2012. The Neo Powders™ were introduced into Molycorp's product mix with the Molycorp Canada acquisition. Sales of NdFeB alloys for the period from April 15, 2011 to December 31, 2011, were approximately 11% of consolidated revenues in the Magnetic Materials and Alloys segment.


(b)	Customers

There were no significant sales to individual customers at the Resources segment in 2012. In prior periods, the Resources segment had the following sales by customers in excess of 15% of consolidated revenues (in millions):



	2011		2010
Hitachi Metals Ltd.	$	92.2	nm
Mitsubishi Unimetals USA	nm		$	8.5
W.R. Grace & Co.—Conn.	nm		$	7.4
Chuden Rare Earth Co. Ltd.	nm		$	5.4
Shin-Etsu Chemical Co.	nm		$	4.0

nm = not material

Sales from the Magnetic Materials and Alloys segment to Santoku Corporation for the period from April 15, 2011 to December 31, 2011, were $48.8 million, or approximately 12% of the Company’s consolidated revenues.